2009
DOI: 10.1016/j.talanta.2008.09.046
|View full text |Cite
|
Sign up to set email alerts
|

A novel application of the T-cell for flow-through dissolution: The case of bioceramics used as ibuprofen carrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(19 citation statements)
references
References 24 publications
0
19
0
Order By: Relevance
“…Indeed, several methods described in the literature try to simulate in vivo conditions and to avoid non-physiological turbulence. In most cases, loaded scaffolds are soaked in a beaker, a bottle or a sampling tube and/or in a culture chamber with or without controlled agitation (Guicheux et al 1997;Paul & Sharma 1999;Krajewski et al 2000;Perry et al 2002;Hasegawa et al 2004;Murugan & Ramakrishna 2004;Palazzo et al 2005;Medvecky et al 2007;Melville et al 2008;Victor & Kumar 2008;Chevalier et al 2009). Released tests are usually performed considering only low volumes (from 3 up to 150 ml) of various dissolution media (phosphate buffer, saline physiological solution, SBF, etc.).…”
Section: Evaluating the Efficacy Of Bioactive Bone Scaffolds As Drug-mentioning
confidence: 99%
See 1 more Smart Citation
“…Indeed, several methods described in the literature try to simulate in vivo conditions and to avoid non-physiological turbulence. In most cases, loaded scaffolds are soaked in a beaker, a bottle or a sampling tube and/or in a culture chamber with or without controlled agitation (Guicheux et al 1997;Paul & Sharma 1999;Krajewski et al 2000;Perry et al 2002;Hasegawa et al 2004;Murugan & Ramakrishna 2004;Palazzo et al 2005;Medvecky et al 2007;Melville et al 2008;Victor & Kumar 2008;Chevalier et al 2009). Released tests are usually performed considering only low volumes (from 3 up to 150 ml) of various dissolution media (phosphate buffer, saline physiological solution, SBF, etc.).…”
Section: Evaluating the Efficacy Of Bioactive Bone Scaffolds As Drug-mentioning
confidence: 99%
“…) (Perry et al 2002;Hall et al 2004;Chevalier et al 2009). Moreover, it could be beneficial to mimic the blood/plasma flow speed observed at the site of the scaffold's implantation (Baroli 2009).…”
mentioning
confidence: 99%
“…Porous β-TCP pellets were fabricated by wet high-shear granulation followed by spheronization in a Mi-Pro high-shear granulator (Pro-C-epT, Zelzate, Belgium) as described in previous works [18,19]. Tricalcium phosphate powder (Ca 3 (PO 4 ) 2 , Cooper, France) and pregelatinized starch (Sepistab ST 200, Seppic, France) were used as granule skeleton and binder/pore former, respectively.…”
Section: Preparation Of Porous β-Tcp Pelletsmentioning
confidence: 99%
“…Such drug delivery system can also be used for the local treatment of articular inflammatory pathologies such as arthritis. In previous studies [18][19][20][21][22], porous β-TCP pellets were produced by high-shear wet granulation and loaded with ibuprofen by solvent evaporation method. The spherical form and the size of these implants, 900 µm in diameter, can guarantee the filling of complex-shaped bone cavities, while maintaining intergranular spaces of about 180 µm for bone ingrowth.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation